Pharsight

Norton Waterford patents expiration

1. Qvar Redihaler patents expiration

QVAR REDIHALER Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8132712 NORTON WATERFORD Metered-dose inhaler
Sep, 2028

(4 years from now)

US11395889 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(7 years from now)

US10022510 NORTON WATERFORD Dose counters for inhalers, inhalers and methods of assembly thereof
May, 2031

(7 years from now)

US10086156 NORTON WATERFORD Dose counter for inhaler and method for counting doses
May, 2031

(7 years from now)

US10022509 NORTON WATERFORD Dose counter for inhaler having a bore and shaft arrangement
May, 2031

(7 years from now)

US10695512 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator
May, 2031

(7 years from now)

US8931476 NORTON WATERFORD Inhaler
Jul, 2031

(7 years from now)

US10561808 NORTON WATERFORD Dose counter for inhaler having an anti-reverse rotation actuator
Jan, 2032

(7 years from now)

US11865247 NORTON WATERFORD Inhalers and related methods
Jan, 2038

(13 years from now)

US11395888 NORTON WATERFORD Inhalers and related methods
Jan, 2038

(13 years from now)

US11793953 NORTON WATERFORD Inhalers and related methods
Jan, 2038

(13 years from now)

US10792447 NORTON WATERFORD Breath actuated inhaler
Jan, 2039

(14 years from now)

US11559637 NORTON WATERFORD Inhalers and related methods
Jul, 2039

(15 years from now)

US11583643 NORTON WATERFORD Inhalers and related methods
Aug, 2041

(17 years from now)

Drugs and Companies using BECLOMETHASONE DIPROPIONATE ingredient

Market Authorisation Date: 03 August, 2017

Treatment: NA

Dosage: AEROSOL, METERED;INHALATION

More Information on Dosage

QVAR REDIHALER family patents

Family Patents